Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...
News Medical

Manufacturing processes for active pharmaceutical ingredients (APIs)

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
Contract Pharma

Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
News Medical

Amazon Filters offers innovative filtration housings for API manufacturing processes

Amazon Filters has selected the Making Pharmaceuticals Exhibition & Conference 2019 to showcase its latest filter housings and microfiltration filter cartridges which are used in the manufacture of ...
Business Wire

Regis Expands Facilities to Support Rising Demand for U.S.-Based Custom API Pharmaceutical Development and Manufacturing

−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects− MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc. today announced ...
PharmTech

Advancing Pharmaceutical Quality through Integrated Digital Systems and Collaborative Scientific Innovation

PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...
PharmTech

Ensuring API Quality Through a Robust Manufacturer Approval Process

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
ksn.com

INTERNATIONAL PROCESS PLANTS ANNOUNCES PURCHASE OF WORLD-CLASS GRIMSBY, UK API PHARMACEUTICAL MANUFACTURING SITE FROM NOVARTIS

"We are very excited to transition this fully-integrated API Pharmaceutical site, with its substantial reaction capacity, site infrastructure and attractive location, we are confident in the potential ...
Mena FN

Europe Active Pharmaceutical Ingredients (API) Market Trends Analysis Report 2025-2033: EMA Approvals, Advanced Bioprocessing And Contract Manufacturing Partnerships Drive Growth

(MENAFN- GlobeNewsWire - Nasdaq) The Europe API market is driven by increasing demand for generics and specialty medicines due to patent expirations and cost-containment policies. The rise in ...
PharmiWeb

Curia Invests $4 Million to Enhance Sterile API Manufacturing

ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million ...
Mena FN

United States Active Pharmaceutical Ingredients (Apis) Market Research Report 2025-2033: Growth Driven By Generic Drug Growth, Biotech API Innovation, And Rising Investments In ...

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by 2033, growing at a 6.46% CAGR. This ...